Alvotech (ALVO) Non-Current Deffered Revenue (2021 - 2025)

Alvotech (ALVO) posted Non-Current Deffered Revenue of $5.5 million for Q4 2025, down 93.19% on a QoQ basis from $80.7 million in Q4 2024, and down 93.19% year-over-year from $80.7 million in Q4 2024.

Alvotech (ALVO) Non-Current Deffered Revenue (2021 - 2025) Analysis & Trends

Alvotech's Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at $5.5 million for Q4 2025.

  • Quarterly Non-Current Deffered Revenue fell 93.19% year-over-year to $5.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.5 million (down 93.19% YoY) and the FY2025 annual result came in at $5.5 million, down 93.19% from the prior year.
  • Non-Current Deffered Revenue was $5.5 million for Q4 2025 at Alvotech, down from $80.7 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $80.7 million in Q4 2024 and bottomed at $5.5 million in Q4 2025.
  • A 5-year average of $52.3 million and a median of $57.0 million in 2022 frame the typical range for Non-Current Deffered Revenue.
  • Annual changes were most pronounced in 2023 — Non-Current Deffered Revenue gained 28.49% — and 2025, when it tumbled 93.19%.
  • Alvotech's Non-Current Deffered Revenue stood at $44.8 million in 2021, then rose by 27.15% to $57.0 million in 2022, then climbed by 28.49% to $73.3 million in 2023, then advanced by 10.18% to $80.7 million in 2024, then tumbled by 93.19% to $5.5 million in 2025.
  • Business Quant data shows ALVO's Non-Current Deffered Revenue at $5.5 million in Q4 2025, $80.7 million in Q4 2024, and $73.3 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 5.50 Mn
Dec 31, 2024 80.72 Mn
Dec 31, 2023 73.26 Mn
Dec 31, 2022 57.02 Mn
Dec 31, 2021 44.84 Mn